77 related articles for article (PubMed ID: 23512591)
1. Tissue and plasma thioredoxin reductase expressions in patients with glioblastoma multiforme.
Kemerdere R; Kacira T; Hanimoglu H; Kucur M; Tanriverdi T; Canbaz B
J Neurol Surg A Cent Eur Neurosurg; 2013 Jul; 74(4):234-8. PubMed ID: 23512591
[TBL] [Abstract][Full Text] [Related]
2. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
[TBL] [Abstract][Full Text] [Related]
3. Relationship between DNA damage and total antioxidant capacity in patients with glioblastoma multiforme.
Tuzgen S; Hanimoglu H; Tanriverdi T; Kacira T; Sanus GZ; Atukeren P; Dashti R; Gumustas K; Canbaz B; Kaynar MY
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):177-81. PubMed ID: 17359903
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
Söderberg A; Sahaf B; Rosén A
Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
[TBL] [Abstract][Full Text] [Related]
5. Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexes.
Koncarevic S; Urig S; Steiner K; Rahlfs S; Herold-Mende C; Sueltmann H; Becker K
Free Radic Biol Med; 2009 Apr; 46(8):1096-108. PubMed ID: 19439228
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice].
Tan Q; Ren XY; Li J; Wang F; Deng SJ; Zeng HH
Ai Zheng; 2009 May; 28(5):472-7. PubMed ID: 19624873
[TBL] [Abstract][Full Text] [Related]
7. The activity and tissue distribution of thioredoxin reductase in basal cell carcinoma.
Sobhani M; Taheri AR; Jafarian AH; Hashemy SI
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2303-7. PubMed ID: 27601162
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex.
Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K
J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423
[TBL] [Abstract][Full Text] [Related]
10. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase.
Bellisola G; Fracasso G; Ippoliti R; Menestrina G; Rosén A; Soldà S; Udali S; Tomazzolli R; Tridente G; Colombatti M
Biochem Pharmacol; 2004 May; 67(9):1721-31. PubMed ID: 15081871
[TBL] [Abstract][Full Text] [Related]
11. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
[TBL] [Abstract][Full Text] [Related]
12. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue.
Lama G; Mangiola A; Anile C; Sabatino G; De Bonis P; Lauriola L; Giannitelli C; La Torre G; Jhanwar-Uniyal M; Sica G; Maira G
Int J Oncol; 2007 Jun; 30(6):1333-42. PubMed ID: 17487353
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.
Gan L; Yang XL; Liu Q; Xu HB
J Cell Biochem; 2005 Oct; 96(3):653-64. PubMed ID: 16088946
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.
Cassidy PB; Edes K; Nelson CC; Parsawar K; Fitzpatrick FA; Moos PJ
Carcinogenesis; 2006 Dec; 27(12):2538-49. PubMed ID: 16777982
[TBL] [Abstract][Full Text] [Related]
15. Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications.
Mangiola A; Lama G; Giannitelli C; De Bonis P; Anile C; Lauriola L; La Torre G; Sabatino G; Maira G; Jhanwar-Uniyal M; Sica G
Clin Cancer Res; 2007 Dec; 13(23):6970-7. PubMed ID: 18056172
[TBL] [Abstract][Full Text] [Related]
16. T2 detection of tumor invasion within segmented components of glioblastoma multiforme.
McMillan KM; Ehtesham M; Stevenson CB; Edgeworth ML; Thompson RC; Price RR
J Magn Reson Imaging; 2009 Feb; 29(2):251-7. PubMed ID: 19161171
[TBL] [Abstract][Full Text] [Related]
17. On the potential of thioredoxin reductase inhibitors for cancer therapy.
Urig S; Becker K
Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
[TBL] [Abstract][Full Text] [Related]
18. Revival of glutathione reductase in human cataractous and clear lens extracts by thioredoxin and thioredoxin reductase, in conjunction with alpha-crystallin or thioltransferase.
Yan H; Harding JJ; Xing K; Lou MF
Curr Eye Res; 2007 May; 32(5):455-63. PubMed ID: 17514531
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
Wang X; Zhang J; Xu T
Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
[TBL] [Abstract][Full Text] [Related]
20. c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme.
Liu W; Fu Y; Xu S; Ding F; Zhao G; Zhang K; Du C; Pang B; Pang Q
J Clin Neurosci; 2011 Jan; 18(1):119-21. PubMed ID: 20832323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
